Joint Formulary & PAD

Olanzapine - Nausea and vomiting (palliative care)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oro-dispersible tablets
Associated Icons :
Off Label
SPC
Restrictions / Comments :
 

Status 2

Red
Formulations :
  • Subcutaneous injection (sc)
Associated Icons :
Off Label
SPC
Restrictions / Comments :
Important

Off-label use.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Olanzapine
Indication :
Nausea and vomiting (palliative care)
Group Name :
Keywords :
Brand Names Include :
Important Information :

Off-label use. Primary care prescribing on request of specialist palliative care team.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Drugs

Below are listed other drugs that are used to treat Nausea and vomiting (palliative care).

Committee Recommendations (0)

  • No records returned.